AZD0754, AZD2287 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-24 in 4mo
ESTIMATED |
READOUT
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Phase 1/2 · Metastatic Prostate Cancer |
AZN ASTRAZENECA PLC | AZD0754, AZD2287 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|